These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6860355)

  • 1. The inhibition of catechol-O-methyltransferase by 2,3-dihydroxypyridine.
    Raxworthy MJ; Youde IR; Gulliver PA
    Biochem Pharmacol; 1983 Apr; 32(8):1361-4. PubMed ID: 6860355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of bulk hydrogen ion concentration upon the apparent kinetic parameters of purified pig liver catechol O-methyltransferase.
    Raxworthy MJ; Gulliver PA
    Biochim Biophys Acta; 1986 Apr; 870(3):417-25. PubMed ID: 3754465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydroxynitrobenzaldehydes and hydroxymethoxynitrobenzaldehydes: synthesis and biological activity as catechol-O-methyltransferase inhibitors.
    Pérez RA; Fernández-Alvarez E; Nieto O; Piedrafita FJ
    J Med Chem; 1992 Nov; 35(24):4584-8. PubMed ID: 1469689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic and inhibition studies on catechol-O-methyltransferase affinity labelling by N-(3,4-dihydroxyphenyl)maleimide.
    Piedrafita FJ; Fernandez-Alvarez E; Nieto O; Tipton KF
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):951-8. PubMed ID: 1417755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics and inhibition studies of catechol O-methyltransferase from the yeast Candida tropicalis.
    Veser J
    J Bacteriol; 1987 Aug; 169(8):3696-700. PubMed ID: 3611026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of catechol-O-methyltransferase by 6,7-dihydroxy-3,4-dihydroisoquinolines related to dopamine: demonstration using liquid chromatography and a novel substrate for O-methylation.
    Cheng BY; Origitano TC; Collins MA
    J Neurochem; 1987 Mar; 48(3):779-86. PubMed ID: 2433397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of the reversible tight-binding inhibition of pig liver catechol-O-methyltransferase by [2-(3,4-dihydroxy-2- nitrophenyl)vinyl]phenyl ketone.
    Pérez RA; Fernández-Alvarez E; Nieto O; Piedrafita FJ
    J Enzyme Inhib; 1994; 8(2):123-31. PubMed ID: 7539072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of rat liver and duodenum soluble catechol-O-methyltransferase by a tight-binding inhibitor OR-462.
    Schultz E; Nissinen E
    Biochem Pharmacol; 1989 Nov; 38(22):3953-6. PubMed ID: 2597177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-adenosylmethionine-dependent protein methylation in mammalian cytosol via tyrphostin modification by catechol-O-methyltransferase.
    Lipson RS; Clarke SG
    J Biol Chem; 2007 Oct; 282(42):31094-102. PubMed ID: 17724020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoaffinity labeling of catechol O-methyltransferase with 8-azido-S-adenosylmethionine.
    Kaiser II; Kladianos DM; Van Kirk EA; Haley BE
    J Biol Chem; 1983 Feb; 258(3):1747-51. PubMed ID: 6337144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benserazide and carbidopa as substrates of catechol-O-methyltransferase: new mechanism of action in Parkinson's disease.
    Hagan RM; Raxworthy MJ; Gulliver PA
    Biochem Pharmacol; 1980 Dec; 29(23):3123-6. PubMed ID: 7447951
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis of bridged catechol-homocysteine derivatives as potential inhibitors of catechol O-methyltransferase.
    Lever OW; Hyman C; White HL
    J Pharm Sci; 1984 Sep; 73(9):1241-4. PubMed ID: 6491941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design, synthesis, and in vitro evaluation of bisubstrate inhibitors for catechol O-methyltransferase (COMT).
    Masjost B; Ballmer P; Borroni E; Zürcher G; Winkler FK; Jakob-Roetne R; Diederich F
    Chemistry; 2000 Mar; 6(6):971-82. PubMed ID: 10785817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonintracellular, cell-associated O-methylation of isoproterenol in the isolated rabbit thoracic aorta.
    Head RJ; Irvine RJ; Barone S; Stitzel RE; de la Lande IS
    J Pharmacol Exp Ther; 1985 Jul; 234(1):184-9. PubMed ID: 4009500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies.
    Chen D; Wang CY; Lambert JD; Ai N; Welsh WJ; Yang CS
    Biochem Pharmacol; 2005 May; 69(10):1523-31. PubMed ID: 15857617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate stereospecificity and selectivity of catechol-O-methyltransferase for DOPA, DOPA derivatives and alpha-substituted catecholamines.
    Gordonsmith RH; Raxworthy MJ; Gulliver PA
    Biochem Pharmacol; 1982 Feb; 31(3):433-7. PubMed ID: 6803810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate.
    Lu H; Meng X; Yang CS
    Drug Metab Dispos; 2003 May; 31(5):572-9. PubMed ID: 12695345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and kinetic mechanism of human brain soluble catechol-O-methyltransferase.
    Jeffery DR; Roth JA
    J Neurochem; 1985 Mar; 44(3):881-5. PubMed ID: 3973595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyl conjugation in uraemia: catechol-O-methyltransferase.
    Pazmiño PA; Weinshilboum RM
    Br J Clin Pharmacol; 1980 Nov; 10(5):509-18. PubMed ID: 7437264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic studies on the O-methylation of dopamine by human brain membrane-bound catechol O-methyltransferase.
    Rivett AJ; Roth JA
    Biochemistry; 1982 Apr; 21(8):1740-2. PubMed ID: 7082642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.